Related Experiment Video

Updated: Mar 27, 2026

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Published on: January 7, 2019

hnRNP A2B1 as a promising therapeutic target for radiomodulatory drug development: evidence from computational and

N S Lubinets^1,2, I S Tonkii¹, V A Sazonova¹

¹Department of Chemoinformatics, ITMO University, Saint-Petersburg, Russia.

Frontiers in Pharmacology

|March 25, 2026

Abstract:

Radiation modulation is critical due to the growing risks of radiation exposure in medical, occupational, and environmental settings. This study explored the potential of heterogeneous nuclear ribonucleoproteins (hnRNPs), particularly hnRNP A2B1, as therapeutic targets for radiomodulatory drugs. In vitro experiments on human endothelial cells exposed to various X-ray doses revealed a dose-dependent increase in hnRNP A2B1 expression, with the histochemical score increasing significantly from 105 to 280 at 8.0 Gy. Using in silico molecular docking, 33 radiomodulatory agents were evaluated for their binding affinities with hnRNP A2B1. Notable ligands, such as hesperidin and psoralidin, demonstrated strong binding affinities (ΔG_tot values: -17.2 and -17.9 kcal⋅mol^-1, respectively). Finally, molecular dynamics simulations confirmed that psoralidin had the highest affinity for hnRNP A2B1 using implicit solvation models. Overall, this study revealed that hnRNP A2B1 is vital for cellular radiomodulation and is a promising target for radiomodulatory drugs that could have radioprotective or radiosensitizing effects.

Keywords:

hesperidin heterogeneous nuclear ribonucleoproteins hnRNP A2B1 molecular docking psoralidin radiomodulating drugs radiomodulators

More Related Videos

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues

Published on: March 21, 2017

Related Concept Videos

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Types of RNA

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Articles linked to this work by shared authors, journal, and citation graph.

Limiting the Parameter Space for Unstable eV-Scale Neutrinos Using IceCube Data.

Physical review letters·2026

Characterization of the Three-Flavor Composition of Cosmic Neutrinos with IceCube.

Physical review letters·2026

NADPH oxidase 2 (NOX2)-independent inducers of neutrophil extracellular traps promote resolution of chronic inflammation.

Redox biology·2026

Drug synergy prediction using heterogeneous stacking ensemble learning.

SAR and QSAR in environmental research·2026

Evidence for a Spectral Break or Curvature in the Spectrum of Astrophysical Neutrinos from 5 TeV to 10 PeV.

Physical review letters·2026

Search for Extremely-High-Energy Neutrinos and First Constraints on the Ultrahigh-Energy Cosmic-Ray Proton Fraction with IceCube.

Physical review letters·2025

See all related articles